Harmelink M - Search Results

1

Lateralisation and depth of the internal mammary chain determined by scintigraphy and by ultrasonography: a comparative study in 124 primary breast cancer patients.

Struikmans H, Scheijmans LJ, van Dalen A, Harmelink M, Westers P, van Isselt JW. Struikmans H, et al. Among authors: harmelink m. Radiother Oncol. 2002 Feb;62(2):159-62. doi: 10.1016/s0167-8140(02)00021-x. Radiother Oncol. 2002. PMID: 11937242

2

[Diurnal triglyceride profiles in 30 young healthy men as a function of diet, fasting triglyceride levels, body composition and insulin sensitivity].

van Oostrom AJ, Castro Cabezas M, Harmelink MJ, Twickler TB, Remijnse TA, Erkelens DW. van Oostrom AJ, et al. Among authors: harmelink mj. Ned Tijdschr Geneeskd. 1999 Sep 11;143(37):1868-72. Ned Tijdschr Geneeskd. 1999. PMID: 10526601 Dutch.

3

IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology.

Allison RL, Mangione CC, Suneja M, Gawrys J, Melvin BM, Belous N, LaCroix M, Harmelink M, Burnett BG, Ebert AD. Allison RL, et al. Among authors: harmelink m. Mol Ther. 2024 Dec 12:S1525-0016(24)00815-3. doi: 10.1016/j.ymthe.2024.12.016. Online ahead of print. Mol Ther. 2024. PMID: 39673131 Free article.

4

Outcomes of early-treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study.

Goedeker NL, Rogers A, Fisher M, Arya K, Brandsema JF, Farah H, Farrar MA, Felker MV, Gibbons M, Hamid OA, Harmelink M, Herbert K, Kichula E, King K, Lakhotia A, Lee BH, Kuntz NL, Parsons J, Rehborg R, Veerapaniyan A, Zaidman CM. Goedeker NL, et al. Among authors: harmelink m. Muscle Nerve. 2024 Dec;70(6):1247-1256. doi: 10.1002/mus.28267. Epub 2024 Oct 6. Muscle Nerve. 2024. PMID: 39370660

5

Adolescent Onset of Muscle Weakness.

Konda MK, Harmelink M. Konda MK, et al. Among authors: harmelink m. Med Clin North Am. 2024 Jan;108(1):173-187. doi: 10.1016/j.mcna.2023.06.015. Epub 2023 Aug 11. Med Clin North Am. 2024. PMID: 37951649 Review.

6

Uncommon Causes of Rhabdomyolysis.

Harmelink M. Harmelink M. Crit Care Clin. 2022 Apr;38(2):271-285. doi: 10.1016/j.ccc.2021.11.004. Crit Care Clin. 2022. PMID: 35369947 Review.

7

Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L; HOPE-2 Study Group. McDonald CM, et al. Among authors: harmelink mm. Lancet. 2022 Mar 12;399(10329):1049-1058. doi: 10.1016/S0140-6736(22)00012-5. Lancet. 2022. PMID: 35279258 Free article. Clinical Trial.

8

Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.

Baker MW, Mochal ST, Dawe SJ, Wiberley-Bradford AE, Cogley MF, Zeitler BR, Piro ZD, Harmelink MM, Kwon JM. Baker MW, et al. Among authors: harmelink mm. Neuromuscul Disord. 2022 Feb;32(2):135-141. doi: 10.1016/j.nmd.2021.07.398. Epub 2021 Jul 27. Neuromuscul Disord. 2022. PMID: 35120759

9

Assessment of cerebral spinal fluid biomarkers and microRNA-mediated disease mechanisms in spinal muscular atrophy patient samples.

Welby E, Rehborg RJ, Harmelink M, Ebert AD. Welby E, et al. Among authors: harmelink m. Hum Mol Genet. 2022 Jun 4;31(11):1830-1843. doi: 10.1093/hmg/ddab365. Hum Mol Genet. 2022. PMID: 34919695

10

Pediatrician Exposure to Neuromuscular Patients.

Harmelink M, Yale E. Harmelink M, et al. WMJ. 2021 Apr;120(1):66-68. WMJ. 2021. PMID: 33974769 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters